The APTMedical Shanghaiheadquartersbase has officially commenced construction in the West Hongqiao Business District.

The project covers a total building area of 58,500 square meters and can accommodate over 1,000 office staff. The base is scheduled for completion and operation in the first half of 2027. It will focus on product development, marketing and medical-engineering innovation, enhancingAPT's ability to serve patients worldwide.

West Hongqiao is actively promoting the development of the "big health" industry. As a key enterprise in this field,APTMedical has been innovating and expanding its product sales and business scale since its establishment in 2022.

APTMedical is a high-tech company specializing in the research, development, production and sales of cardiac electrophysiology and interventional medical devices. Its industrial layout is primarily centered on complete coronary pathways and cardiac electrophysiology devices, with peripheral vascular interventional devices as a key development focus. In January 2021,APTMedical was listed on the STAR Marketof the Shanghai Stock Exchange.

The projectincludes the core headquarters building and multi-story podiums for commercial offices, providing a more convenient and efficient business environment. The commencement of theAPTMedical Shanghaiheadquartersbase marks another significant development in the medical technology sector in Qingpu.